HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Atidarymo kaina

SektoriusFinansų sektorius

210.4 3.34

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

204

Max

210.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-34M

71M

Pardavimai

85M

1.3B

P/E

Sektoriaus vid.

29.8

22.989

Pelnas, tenkantis vienai akcijai

0.08

Dividendų pajamingumas

3.47

Pelno marža

5.575

Darbuotojai

10,910

EBITDA

57M

338M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+44.01% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

3.47%

4.69%

Kitas uždarbis

2026-08-04

Kita Ex Dividend data

2026-08-20

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-793M

4.1B

Ankstesnė atidarymo kaina

207.06

Ankstesnė uždarymo kaina

210.4

Naujienos nuotaikos

By Acuity

50%

50%

157 / 439 reitingas Finance

ConvaTec Group PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat